Investment Trusts

Worldwide Healthcare

WWH:LSE

Worldwide Healthcare

Actions
  • Price (GBX)326.59
  • Today's Change-3.42 / -1.03%
  • Shares traded235.44k
  • 1 Year change+1.58%
  • Beta0.4158
Data delayed at least 20 minutes, as of Apr 19 2024 14:13 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PriceWorldwide Healthcare (Ordinary Share)+3.82%
NAVWorldwide Healthcare (Ordinary Share)+2.06%
Morningstar's BenchmarkMSCI World Health Care GR--

Key statistics

As of last trade Worldwide Healthcare (WWH:LSE) traded at 326.59, -2.66% below its 52-week high of 335.50, set on Feb 28, 2024.
52-week range
Today
286.00Oct 31 2023335.50Feb 28 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding543.03m
Market cap1.79bn GBP
Total assets1.99bn GBP
Total expense ratio0.83%
High329.00
Low326.00
Previous close330.00
Average volume1.39m
YTD Change+5.01%
Beta0.4158
Diluted NAV (est)364.66
Diluted NAV (last pub)369.84
Premium/Discount-9.50%
Net Gearing+0.81%
Annual div (ADY)3.10
GBX
Annual div yield (ADY)0.94%
Div ex-dateNov 23 2023
Div pay-dateJan 11 2024
Data delayed at least 20 minutes, as of Apr 19 2024 14:13 BST.
More ▼

Board of Directors

1/6

Doug McCutcheon, Chairman

2/6

Sven H. Borho

3/6

Humphrey van der Klugt

4/6

Dr Bandhana (Bina) Rawal

5/6

Tim Livett

6/6

Joanne Parfrey

Contact

Registered Office:
One Wood Street
London
EC2V 7WS

Alternative Investment Fund Manager, Company Secretary and Administrator
Frostrow Capital LLP
25 Southampton Buildings
London
WC2A 1AL

T: 0203 008 4910
E: info@frostrow.com
W: www.frostrow.com
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.